IM Cannabis (IMCC) Cash & Equivalents (2019 - 2026)

IM Cannabis' Cash & Equivalents history runs 8 years deep, the most recent figure standing at $732122.5 for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 24.37% year-over-year to $732122.5 in Q1 2026; TTM through Mar 2026 was $732122.5, a 24.37% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, up 210.23% from the prior year.
• Cash & Equivalents eased to $732122.5 in Q1 2026 per IMCC's latest filing, from $2.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $8.1 million in Q1 2022 and bottomed at $511798.4 in Q2 2024.
• The 5-year median for Cash & Equivalents is $983421.7 (2023), against an average of $1.8 million.
• Across the five-year window, Cash & Equivalents surged 723.23% in 2022 and tumbled 87.11% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $1.8 million in 2022, then retreated by 26.19% to $1.3 million in 2023, then plunged by 53.61% to $617777.8 in 2024, then surged by 216.54% to $2.0 million in 2025, then slumped by 62.56% to $732122.5 in 2026.
• Per Business Quant, the three latest IMCC Cash & Equivalents figures stand at $732122.5 (Q1 2026), $2.0 million (Q4 2025), and $858882.6 (Q3 2025).